GC Biopharma Corp.
No trades
Fundamentals and stats
EPS and revenue snapshot
For the next quarter, analysts expect 93.23 KRW in earnings per share and 437.60 B KRW in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise